Shuli Zhao

机构：University of Science and Technology of China, China Pharmaceutical University, Nanjing Medical University · ORCID：0000-0002-3610-2418

发表论文 97 篇 · 总被引 3063 次 · h-index 30

代表论文

• Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis (2023 · International Journal of Biological Sciences · 被引 24)
• FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer (2024 · Cell Death and Disease · 被引 19)
• Human β-defensins: The multi-functional natural peptide (2024 · Biochemical Pharmacology · 被引 17)
• FoxO1 promotes ovarian cancer by increasing transcription and METTL14‐mediated m6A modification of SMC4 (2024 · Cancer Science · 被引 15)
• 2bRAD-M reveals the difference in microbial distribution between cancerous and benign ovarian tissues (2023 · Frontiers in Microbiology · 被引 12)
• Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome (2024 · Journal of Translational Medicine · 被引 11)